16 articles for thisTarget

---

The following articles (labelled with PubMed ID or TBD) are for your review

PMID	Data	Article Title	Organization
8691426	114	Synthesis and structure-activity relationships of 2-substituted D-tryptophan-containing peptidic endothelin receptor antagonists: importance of the C-2 substituent of the D-tryptophan residue for endothelin A and B receptor subtype selectivity.	Tsukuba Research Institute
1315867	31	Endothelin: a new challenge.	Warner-Lambert
9873432	52	Endothelin antagonists: discovery of EMD 122946, a highly potent and orally active ETA selective antagonist.	Merck
	30	IRL 2500: A potent ETB selective endothelin antagonist	TBA
	20	Synthesis of 2-substituted d-tryptophan-containing peptide derivatives with endothelin receptor antagonist activity	TBA
	56	Pyridazinones with a pendant acylsulfonamide moiety as endothelin receptor antagonists	TBA
11985472	185	Structure-activity relationships of a novel class of endothelin-A receptor antagonists and discovery of potent and selective receptor antagonist, 2-(benzo[1,3]dioxol-5-yl)-6-isopropyloxy-4-(4-methoxyphenyl)-2H-chromene-3-carboxylic acid (S-1255). 1. Study on structure-activity relationships and bas	Shionogi
11229770	28	Peptoids as endothelin receptor antagonists.	Ranbaxy Laboratories
10969989	45	Discovery and synthesis of a potent sulfonamide ET(B) selective antagonist.	Shionogi
27321813	286	From bosentan (Tracleer®) to macitentan (Opsumit®): The medicinal chemistry perspective.	Actelion Pharmaceuticals
9379441	100	Pyrrolidine-3-carboxylic acids as endothelin antagonists. 2. Sulfonamide-based ETA/ETB mixed antagonists.	Abbott Laboratories
9022798	58	Potent and selective non-benzodioxole-containing endothelin-A receptor antagonists.	Abbott Laboratories
8676339	143	2,4-Diarylpyrrolidine-3-carboxylic acids--potent ETA selective endothelin receptor antagonists. 1. Discovery of A-127722.	Abbott Laboratories
8632420	112	Azole endothelin antagonists. 2. Structure-activity studies.	Abbott Laboratories
8632419	50	Azole endothelin antagonists. 1. A receptor model explains an unusual structure-activity profile.	Abbott Laboratories
7473559	85	Structure-activity relationships of cyclic pentapeptide endothelin A receptor antagonists.	Tsukuba Research Institute